You Searched For "remdesivir coronavirus drug" and got 16 results
Sort By:
Remdesivir drug fails to reduce mortality or hospital stay of COVID-19 patients, says WHO study
Remdesivir, one of the earliest touted treatments for COVID-19 in the world, is not effective in pr…
How remdesivir drug can save lives in nations with lower hospital capacity
Amid news that the US has bought up virtually the entire global supply of remdesivir, a new study o…
Drugs used to combat COVID-19 — what works and what doesn’t
(Disclaimer: This should not be considered medical advice. Please check with your doctor before tak…
Remdesivir is an effective coronavirus treatment claims study
The news about remdesivir, the investigational anti-viral drug that has shown early promise in the …
Remdesivir linked to reduced risk of death in severe Covid-19 patients
This is an important finding that requires confirmation in prospective clinical trials, Gilead s…
Inside the treacherous black market for Remdesivir in India— from private hospitals to distributors
The black market for drugs that could treat COVID-19 is surging in India, especially when it comes …
The utter chaos and confusion over Remdesivir in India is making the COVID-19 second wave worse
Remdesivir is not a proven treatment against COVID-19. Governments have said it, the courts hav…
Cipla says COVID-19 drug Remdesivir will hit market this week
As India faces a shortage of Covid-19 drug Remdesivir, the pharmaceutical company Cipla said it wil…
More than 20 COVID drugs identified to keep the virus from replicating
"Remdesivir has proven successful at shortening the recovery time for patients in the hospital…
The curious case of Remdesivir — the coronavirus ‘miracle drug’ may be overhyped, suggests Lancet study
Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases (NIAID)…
Cipla signs licensing agreement with Gilead to manufacture and sell antiviral drug remdesivir
Leading pharmaceutical company Cipla on Wednesday announced it has signed a non-exclusive licensing…
The first approved COVID-19 drug is far from 'amazing'
These are Business Insider's biggest healthcare stories for October 26.
Lydia Ramsey Pflanzer
Gilead rises after pricing its coronavirus-fighting drug remdesivir
"We believe that pricing remdesivir well below value is the right and responsible thing to do," sai…
Carmen Reinicke
These are the companies that are making Remdesivir in India
Zydus Cadila has launched Remdesivir under the brand name Remdac, used to treat patients sufferin…
US FDA approves emergency use of Remdesivir for COVID-19 patients
The US Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for the e…
Gilead has yet to set a price for the coronavirus treatment remdesivir, but an influential drug pricing watchdog says it could be worth up to $4,500 per patient
The nonprofit group often finds drugs to be overpriced. For the first potential COVID-19 drug, it s…